These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Study on changes of osmotic and mechanical leukocytal resistance after the administration of polysaccharide antigen of bacterial origin in a subject with cyclic neutropenia syndrome]. GELLI G; DELLA SANTA L; VIGNALE AM Minerva Pediatr; 1961 Aug; 13():1006-11. PubMed ID: 13897643 [No Abstract] [Full Text] [Related]
26. Cyclic neutropenia in an infant. BORNE S Pediatrics; 1949 Jul; 4(1):70-8. PubMed ID: 18133018 [No Abstract] [Full Text] [Related]
27. Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis. Elalfy M; Wali YA; Qari M; Al Damanhouri G; Al-Tonbary Y; Yazman D; Al Hawsawi Z; Karakas Z; Kilinc Y; Yesilipek MA; Badr M; Elsafy U; Salama M; Abdel Rahman Y; Shebl S; Stilman A; Toiber Temin N; Tricta F Pediatr Blood Cancer; 2014 May; 61(5):879-84. PubMed ID: 24376176 [TBL] [Abstract][Full Text] [Related]
30. [Contribution to the study of cyclic neutropenias]. LORRE J; DENYS P Acta Paediatr Belg; 1960; 14():178-89. PubMed ID: 13763566 [No Abstract] [Full Text] [Related]
32. Recurrent pyodermas and gingivitis associated with periodic cyclic neutropenia. BECKER FT; COVENTRY WD AMA Arch Derm Syphilol; 1951 Dec; 64(6):799-800. PubMed ID: 14867927 [No Abstract] [Full Text] [Related]
33. Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit? Pick AM; Nystrom KK J Pharm Pract; 2014 Oct; 27(5):447-52. PubMed ID: 25124379 [TBL] [Abstract][Full Text] [Related]
34. [Successful cortisone therapy in cyclic agranulocytosis complicated with lung abscess]. D-FINCZICZKY K; KOBULNICZKY E; V-SZABOLCS P Orv Hetil; 1956 Sep; 97(40):1118-9. PubMed ID: 13388351 [No Abstract] [Full Text] [Related]
35. The oral manifestations of cyclic (periodic) neutropenia. Does periadenitis mucosa necrotica recurrens (Sutton) exist? A need for reevaluation. GORLIN RJ; CHAUDHRY AP Arch Dermatol; 1960 Sep; 82():344-8. PubMed ID: 13851317 [No Abstract] [Full Text] [Related]
36. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. Whiskey E; Taylor D CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527 [TBL] [Abstract][Full Text] [Related]
38. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia. Stip E; Langlois R; Thuot C; Mancini-Marïe A Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752 [TBL] [Abstract][Full Text] [Related]
39. Treatment of drug-induced agranulocytosis with haematopoietic growth factors: a review of the clinical experience. Vial T; Gallant C; Choqu-Kastylevsky G; Descotes J BioDrugs; 1999 Mar; 11(3):185-200. PubMed ID: 18031129 [TBL] [Abstract][Full Text] [Related]
40. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]